Project Number PCTRB-13-31654 Agency/Funding Organization Alzheimer's Association Funding Year 2013 View Full Project Details for Phase 2a levetiracetam trial for AD-associated network hyperexcitability Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator VOSSEL, KEITH ALAN Principal Investigator First Name KEITH Principal Investigator Last Name VOSSEL Awardee Organization University of California San Francisco Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA 2013: PCT RFA FY Overall Cost $200,000 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Snyder, Heather hsnyder@alz.org
